We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
The VDEC clinical evaluation team works to support vaccine and therapeutic development by providing expertise in immunological and functional assays used to support clinical trials (Phase I to IV)
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Description of UKHSA adult surveillance programmes for COVID-19.
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
How investigators and sponsors should manage clinical trials during COVID-19
Public health principles for reducing the spread of respiratory infections, including COVID-19, in the workplace.
Volume 29 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
To better understand Mpox and its spread within the UK, VDEC developed an immunoassay to assess immune responses to Mpox infection and new vaccines.
How to apply for simultaneous review of veterinary medicine submissions to the Australian Pesticides and Veterinary Medicines Authority (APVMA) and the VMD.
Volume 40 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
The eight-strong FluMap consortium, headed by the world-leading research team at the Animal and Plant Health Agency has made a number of bird flu discoveries.
The process for the simultaneous review of veterinary drug submissions by Health Canada’s Veterinary Drugs Directorate and the UK's Veterinary Medicines Directorate.
Paper prepared by academics on what we know on COVID-19 immunology research and what the research priorities are.
A list of RPC statements explaining the absence of Impact Assessments (IAs) and/or RPC opinions alongside published legislative proposals.
Evidence reviews conducted by the Clinical and Public Health Response Evidence Review team and the Science Evidence Review team within UKHSA.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).